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We have conceptualized new molecular entities (bicyclitols)
in which two conduritol and two carbasugar moieties are
embedded in a polyhydroxylated decahydronaphthalene
framework and achieved their syntheses in a stereo- and
regioselective manner. One of the bicyclitols was found to be
a potent and selective a-glucosidase inhibitor.
Conduritols 1 (six diastereomers designated A–F are known)1
and carbasugars 2 are a class of polyhydroxylated cyclohexa-
noids that have evoked a great deal of synthetic interest in recent
years.1,2 In view of their promising therapeutic potential in the
management of wide ranging disorders like diabetes, viral
infections, HIV and cancer among others, many analogues and
structural variants of 1 and 2 have been synthesized and their
biological activities, particularly glycosidase inhibition has
been evaluated.3 Considering the fundamental importance of
competitive and specific glycosidase inhibition in new drug
development, we have conceived of a new family of poly-
hydroxylated polycyclic systems (polycyclitols) represented by
3 as potential glycomimics.4 Bicyclitol 3 is an interesting entity
which can be considered as a hybrid of two conduritols with
shared, common ring junction carbon atoms. Alternately, 3 can
be regarded as a hybrid of two carbasugars A and B (see, bold
portions in 4 and 5), both of which are ring annulated. Herein,
we report the stereo- and regioselective syntheses of two
polycyclitols 6 and 7 based on the general structure 3, and show
that one of them 6 is a potent and selective inhibitor of a-
glucosidase.
Our synthesis of 6 emanated from the readily available Diels–
Alder adduct 8 of 5,5-dimethoxy-1,2,3,4-tetrachlorocyclo-
pentadiene and p-benzoquinone, which was elaborated to the
tricyclic diene 9 following the tactically modified literature
procedure.5 Exhaustive OsO4 mediated dihydroxylation of 9
occurred exclusively from the exo-face to furnish the all cis-
tetrol 10.6 Selective monoprotection and reductive dechlorina-
tion in 10 led to the symmetrical 11.6 Careful deketalisation in
11, while retaining the acetonide protective group led to the
desired norbornen-7-one† 12, Scheme 1. Thermally induced
decarbonylation in 12 to the cyclohexadiene derivative 136 was
smooth and further catalytic, OsO4 mediated double dihydrox-
ylation proceeded stereoselectively to furnish 14 as a single
diastereomer. Acetonide deprotection in 14 provided the
octahydroxydecahydronaphthalene 6,6 a hybrid of conduritols
D (right ring) and E (left ring), Scheme 1. The absence of
symmetry in 6 and 14, revealed through the presence of 10 and
13 lines, respectively, in the 13C NMR spectra, uniquely settled
the stereochemical pattern present in these bicyclitols. Bicycli-
tol 6 was screened against a- and b-glucosidases (from Bakers’
yeast and almonds, respectively) that accept corresponding p-
nitrophenylglycosides as substrates and it was very satisfying to
find impressive inhibition of a-glucosidase with a Ki value7 of
12 mM (cf. Ki = 25.4 mM for deoxynojirimycin, DNJ).
Interestingly, 6 exhibited no significant inhibitory activity
Scheme 1 Reagents and conditions: i, OsO4 (cat.), NMMO, Me2CO:tBuOH
(5+2), 2 d, 66%; ii, (a) Amberlyst-15, acetone, mol. sieves 4 A, 75%; (b) Na,
liq. NH3, THF, EtOH, 49%; iii, Amberlyst-15, acetone, 98%; iv, C6H5NO2,
160 °C, 62%; v, OsO4 (cat.), NMMO, Me2CO+H2O+tBuOH (5+5+2), 85%;
vi, 30% CF3COOH, 95%.
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against b-glucosidase at mM concentration, thus highlighting
its selectivity towards a-glucosidase.
The promising inhibitory profile of 6, spurred us to prepare a
diastereomer 7 of 6. Diels–Alder adduct 8 was readily
transformed to the endo,endo-diol-15.6 Deketalisation to 16 and
decarbonylation led to the cyclohexadiene derivative 17,6
Scheme 2. Catalytic OsO4 mediated double dihydroxylation
was once again highly diastereoselective and the hexahydroxy-
acetal 18 was obtained. Acetonide deprotection in 18 delivered
the projected bicyclitol 7,6 a hybrid of conduritols A (right ring)
and E (left ring). Once again the lack of symmetry (13C NMR)
in 7 and 18, uniquely delineated the stereochemical pattern
generated during the double dihydroxylation of 17. When 7 was
evaluated for its inhibitory activity against a- and b-glucosi-
dases, no significant inhibition was observed for either of the
enzymes at mM concentrations, indicating that stereochemical
alterations in the hydroxy substituents has a major impact on the
enzyme inhibitory activity (cf. 6). This result provides further
impetus to prepare many more diastereomers of 6 and 7 for
further evaluation and efforts towards that end are underway.
In short, we have devised a new family of glycosidase
inhibitors, composed of conduritol and carbasugar hybrid
structures and describe the synthesis of an octahydroxydeca-
hydronaphthalene, which exhibits significant and selective
a-glucosidase activity.
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Scheme 2 Reagents and conditions: i, Amberlyst-15, acetone, 95%; ii,
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